Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04861064 · ClinicalTrials.gov registry record · Phase 2
Weekly Sirolimus Therapy
A Phase 2 study of Lymphatic Malformation and Venous Malformation, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT04861064 is a Phase 2 study of Lymphatic Malformation and Venous Malformation that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04861064, a Phase 2 study of Lymphatic Malformation and Venous Malformation, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
In current practice, options for venous and lymphatic malformations remain limited. Recently an oral medication, sirolimus, has been found to benefit patients when taken once or twice a day for several months. Unfortunately there are many side effects associated with this medication, some of which can be severe including, neutropenia, oral ulcerations, and lab abnormalities. The purpose of this study is to determine if once weekly dosed sirolimus will be effective for the treatment of venous and lymphatic malformations. Additionally, the study will evaluate patient satisfaction and identify adverse effects. Participants will be on the medication for 6 months with an option to continue after this time period.
Conditions Studied
Interventions
- DRUG Sirolimus
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04861064
The ClinicalTrials.gov registry entry for NCT04861064 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lymphatic Malformation appearing as the primary indexed condition, and to 1 intervention - of which Sirolimus is the first listed.
NCT04861064 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT04861064 about?
NCT04861064 is a clinical study titled "Weekly Sirolimus Therapy". In current practice, options for venous and lymphatic malformations remain limited. Recently an oral medication, sirolimus, has been found to benefit patients when taken once or twice a day for several months. Unfortunately there are many side effects associated with this medication, some of which c...
What is the current status of trial NCT04861064?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2022-01-18. Estimated completion is 2027-12.
What conditions does trial NCT04861064 study?
This clinical trial studies the following conditions: Lymphatic Malformation, Venous Malformation.
What interventions are being tested in trial NCT04861064?
The interventions under investigation include: Sirolimus (DRUG).
Who is sponsoring clinical trial NCT04861064?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04861064 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphatic Malformation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.